Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) Is an Independent Risk Factor for the Development of Ischemic Heart Disease ― A 10-Year Cohort Study ―
The presence of MASLD, but not other SLDs, is an independent risk factor for new onset of IHD during a 10-year follow-up period.
Authors
- Toshifumi Ogawa
- Kazuma Mori (ORCID: https://orcid.org/0000-0002-0212-1039)
- Nagisa Hanawa (ORCID: https://orcid.org/0009-0000-8702-1645)
- Yukinori Akiyama (ORCID: https://orcid.org/0000-0002-1950-8213)
- Kei Nakata (ORCID: https://orcid.org/0000-0003-0747-7103)
- Marenao Tanaka (ORCID: https://orcid.org/0000-0002-6575-9996)
- Hidemichi Kouzu (ORCID: https://orcid.org/0000-0001-7815-1464)
- Tatsuya Sato (ORCID: https://orcid.org/0000-0001-7876-1772)
- Itaru Hosaka (ORCID: https://orcid.org/0000-0002-4005-8229)
- Masato Furuhashi (ORCID: https://orcid.org/0000-0002-0145-3541)
- Wataru Kawaharata
- Toru Suzuki
- Hiroki Aida (ORCID: https://orcid.org/0009-0007-2615-6010)
Institutions
- Sapporo Medical University (JP)
- Tanaka Holdings (Japan) (JP)
- Teine Keijinkai Hospital (JP)
- National Defense Medical College (JP)
Publication Details
- Journal
- Circulation Reports
- Published
- 2025-03-31
- DOI
- https://doi.org/10.1253/circrep.cr-25-0019
- Citations
- 8
- Primary Topic
- Liver Disease Diagnosis and Treatment
- Type
- article
- Field-Weighted Citation Impact
- 10.83